This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Y. Chen, A. Mestek, J. Liu, and L. Yu, Molecular cloning of a rat kappa opioid receptor reveals sequence similarities to the mu and delta opioid receptors, Biochem. J. 295:625 (1993).
S. Li, J. Zhu, C. Chen, Y.-W. Chen, J.K. DeRiel, B. Ashby, and L.-Y. Liu-Chen, Molecular cloning and expression of a rat kappa opioid receptor, Biochem. J. 295:629 (1993).
C.J. Evans, D. Keith, K. Magendzo, H. Morrison, and R.H. Edwards, Cloning of a delta opioid receptor by functional expression, Science 258:1952 (1992).
D.J.J. Carr, B.R. DeCosta, C.-H. Kim, A.E. Jacobson, V. Guarcello, K.C. Rice, and J.E. Blalock, Opioid receptors on cells of the immune system: evidence for δ-and κ-classes, J. Endocrinol. 122:161 (1989).
J.M. Bidlack, L.D. Saripalli, and D.M.P. Lawrence, κ-opioid binding sites on a murine lymphoma cell line, Eur. J. Pharmacol. 227:257 (1992).
L.F. Chuang, T.K. Chuang, K.F. Killam, Jr., A.J. Chuang, H.-F. Kung, L. Yu, and R.Y. Chuang, Delta opioid receptor gene expression in lymphocytes, Biochem. Biophys. Res. Commun. 202:1291 (1994).
S.M. Belkowski, J. Zhu, L.-Y. Liu-Chen, T.K. Eisenstein, M.W. Adler, and T.J. Rogers, Sequence of κ-opioid receptor cDNA in the R1.1 thymoma cell line, J. Neuroimmunol. 62:113 (1995).
M. Sedqi, S. Roy, S. Ramakrishnan, R. Elde, and H.H. Loh, Complementary DNA cloning of a μ-opioid receptor from rat peritoneal macrophages, Biochem. Biophys. Res. Commun. 209:563 (1995).
H.M. Johnson, E.M. Smith, B.A. Torres, and J.E. Blalock, Regulation of the in vitro antibody response by neuroendocrine hormones, Proc. Natl. Acad. Sci. USA 79:4171 (1982).
D.D. Taub, T.K. Eisenstein, E.B. Geller, M.W. Adler, and T.J. Rogers, Immunomodulatory activity of μ-and κ-selective opioid agonists, Proc. Natl. Acad. Sci. USA 88:360 (1991).
N.R. Pellis, C. Harper, and N. Dafny, Suppression of the induction of delayed-type hypersensitivity in rats by repetitive morphine treatments, Exp. Neurol. 93:92 (1986).
R.J. Weber and A. Pert, The periaqueductal gray matter mediates opiate-induced immunosuppression, Science 245:188 (1989).
I. Szabo, M. Rojavin, J.L. Bussiere, T.K. Eisenstein, M.W. Adler, and T.J. Rogers, Suppression of peritoneal macrophage phagocytosis of Candida albicans by opioids, J. Pharmacol. Exp. Ther. 267:703 (1993).
M.R. Ruff, S.M. Wahl, S. Mergenhagen, and C.B. Pert, Opiate receptor-mediated chemotaxis of human monocytes, Neuropeptides 5:363 (1985).
D.E. Van Epps and L. Saland, β-endorphin and met-enkephalin stimulate human peripheral blood mononuclear cell chemotaxis, J. Immunol. 132:3046 (1984).
M. Grimm, A. Ben-Baruch, D.D. Taub, O.M.Z. Howard, J.H. Resau, J.M. Wang, H. Ali, R. Richardson, R. Snyderman, and J.J. Oppenheim, Opiates transdeactivate chemokine receptors: delta and mu opiate-receptor mediated heterologous desensitization, J. Exp. Med. 188:317 (1998).
Y. Liu, D.J. Blackbourn, L.F. Chuang, K.F. Killam, and R.Y. Chuang, Effects of in vivo and in vitro administration of morphine sulfate upon Rhesus macaque polymorphonuclear cell phagocytosis and chemotaxis, J. Pharmacol. Exp. Ther. 265:533 (1992).
C. Alicea, S.M. Belkowski, T.K. Eisenstein, M.W. Adler, and T.J. Rogers, Inhibition of primary murine macrophage cytokine production in vitro following treatment with the κ-opioid agonist U50,488H, J. Neuroimmunol. 64:83 (1996).
S.M. Belkowski, C. Alicea, T.K. Eisenstein, M.W. Adler, and T.J. Rogers, Inhibition of interleukin-1 and tumor necrosis factor-α synthesis following treatment of macrophages with the kappa opioid agonist U50,488H, J. Pharmacol. Exp. Ther. 273:1491 (1995).
S. Roy, R.A. Barke, and H.H. Loh, MU-opioid receptor-knockout mice: role of mu-opioid receptor in morphine mediated immune functions, Brain Res. Mol. Brain Res. 61:190 (1998).
S. Roy, K.J. Cain, R.B. Chapin, and R.G. Charboneau, Morphine modulates NF-κB activation in macrophages, Biochem. Biophys. Res. Commun. 245:392 (1998).
F. Mennicken, R. Maki, E.B. de Souza, and R. Quirion, Chemokines and chemokine receptors in the CNS: a possible role in neuroinflammation and patterning, Trends Pharmacological Sci. 20:73 (1999).
B.J. Doranz, J. Rucker, Y. Yi, R.J. Smyth, M. Samson, S.C. Peiper, M. Parmentier, R.G. Collman, and R.W. Doms, A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors, Cell 85:1149 (1996).
S. Sozzani, S. Ghezzi, G. Iannolo, W. Luini, A. Borsatti, N. Polentarutti, A. Sica, M. Locati, C. Mackay, T.N.C. Wells, et al., Interleukin-10 increases CCR5 expression and HIV infection in human monocytes, J. Exp. Med. 187:439 (1998).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Kluwer Academic Publishers
About this chapter
Cite this chapter
Szabo, I. et al. (2002). Interactions of Opioid Receptors, Chemokines, and Chemokine Receptors. In: Friedman, H., Klein, T.W., Madden, J.J. (eds) Neuroimmune Circuits, Drugs of Abuse, and Infectious Diseases. Advances in Experimental Medicine and Biology, vol 493. Springer, Boston, MA. https://doi.org/10.1007/0-306-47611-8_8
Download citation
DOI: https://doi.org/10.1007/0-306-47611-8_8
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-46466-9
Online ISBN: 978-0-306-47611-2
eBook Packages: Springer Book Archive